164 related articles for article (PubMed ID: 15354396)
1. Coenzyme Q10 serum levels in Huntington's disease.
Andrich J; Saft C; Gerlach M; Schneider B; Arz A; Kuhn W; Müller T
J Neural Transm Suppl; 2004; (68):111-6. PubMed ID: 15354396
[TBL] [Abstract][Full Text] [Related]
2. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.
Smith KM; Matson S; Matson WR; Cormier K; Del Signore SJ; Hagerty SW; Stack EC; Ryu H; Ferrante RJ
Biochim Biophys Acta; 2006 Jun; 1762(6):616-26. PubMed ID: 16647250
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice.
Stack EC; Smith KM; Ryu H; Cormier K; Chen M; Hagerty SW; Del Signore SJ; Cudkowicz ME; Friedlander RM; Ferrante RJ
Biochim Biophys Acta; 2006 Mar; 1762(3):373-80. PubMed ID: 16364609
[TBL] [Abstract][Full Text] [Related]
4. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases.
Beal MF
Biofactors; 1999; 9(2-4):261-6. PubMed ID: 10416039
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model.
Schilling G; Coonfield ML; Ross CA; Borchelt DR
Neurosci Lett; 2001 Nov; 315(3):149-53. PubMed ID: 11716985
[TBL] [Abstract][Full Text] [Related]
6. Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.
Hickey MA; Zhu C; Medvedeva V; Franich NR; Levine MS; Chesselet MF
Mol Cell Neurosci; 2012 Feb; 49(2):149-57. PubMed ID: 22044764
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease.
Huntington Study Group
Neurology; 2001 Aug; 57(3):397-404. PubMed ID: 11502903
[TBL] [Abstract][Full Text] [Related]
8. Coenzyme Q10 as a possible treatment for neurodegenerative diseases.
Beal MF
Free Radic Res; 2002 Apr; 36(4):455-60. PubMed ID: 12069110
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease.
Ferrante RJ; Andreassen OA; Dedeoglu A; Ferrante KL; Jenkins BG; Hersch SM; Beal MF
J Neurosci; 2002 Mar; 22(5):1592-9. PubMed ID: 11880489
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects.
; Hyson HC; Kieburtz K; Shoulson I; McDermott M; Ravina B; de Blieck EA; Cudkowicz ME; Ferrante RJ; Como P; Frank S; Zimmerman C; Cudkowicz ME; Ferrante K; Newhall K; Jennings D; Kelsey T; Walker F; Hunt V; Daigneault S; Goldstein M; Weber J; Watts A; Beal MF; Browne SE; Metakis LJ
Mov Disord; 2010 Sep; 25(12):1924-8. PubMed ID: 20669312
[TBL] [Abstract][Full Text] [Related]
11. Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice.
Schilling G; Savonenko AV; Coonfield ML; Morton JL; Vorovich E; Gale A; Neslon C; Chan N; Eaton M; Fromholt D; Ross CA; Borchelt DR
Exp Neurol; 2004 May; 187(1):137-49. PubMed ID: 15081595
[TBL] [Abstract][Full Text] [Related]
12. Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10.
Biglan KM; Dorsey ER; Evans RV; Ross CA; Hersch S; Shoulson I; Matson W; Kieburtz K;
J Huntingtons Dis; 2012; 1(1):65-9. PubMed ID: 25063191
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress markers in hemodialysis and peritoneal dialysis patients, including coenzyme Q10 and ischemia-modified albumin.
Mehmetoglu I; Yerlikaya FH; Kurban S; Erdem SS; Tonbul Z
Int J Artif Organs; 2012 Mar; 35(3):226-32. PubMed ID: 22461118
[TBL] [Abstract][Full Text] [Related]
16. The effect of short-term coenzyme Q10 supplementation and pre-cooling strategy on cardiac damage markers in elite swimmers.
Emami A; Tofighi A; Asri-Rezaei S; Bazargani-Gilani B
Br J Nutr; 2018 Feb; 119(4):381-390. PubMed ID: 29498347
[TBL] [Abstract][Full Text] [Related]
17. Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease.
Beal MF; Shults CW
Biofactors; 2003; 18(1-4):153-61. PubMed ID: 14695931
[No Abstract] [Full Text] [Related]
18. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.
Koroshetz WJ; Jenkins BG; Rosen BR; Beal MF
Ann Neurol; 1997 Feb; 41(2):160-5. PubMed ID: 9029064
[TBL] [Abstract][Full Text] [Related]
19. Coenzyme Q10: a review of its promise as a neuroprotectant.
Young AJ; Johnson S; Steffens DC; Doraiswamy PM
CNS Spectr; 2007 Jan; 12(1):62-8. PubMed ID: 17192765
[TBL] [Abstract][Full Text] [Related]
20. Serum coenzyme Q10 levels are associated with coronary flow reserve in hemodialysis patients.
Macunluoglu B; Kaya Y; Atakan A; Ari E; Kaspar C; Demir H; Alp HH; Asicioglu E; Kedrah AE
Hemodial Int; 2013 Jul; 17(3):339-45. PubMed ID: 23185999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
